- Home
- BRN vs PMN Comparison
BRN vs PMN Comparison
Compare BRN & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- PMN
- Stock Information
- Founded
- BRN 1956
- PMN 2004
- Country
- BRN United States
- PMN Canada
- Employees
- BRN N/A
- PMN N/A
- Industry
- BRN Oil & Gas Production
- PMN Pharmaceuticals and Biotechnology
- Sector
- BRN Energy
- PMN Health Care
- Exchange
- BRN Nasdaq
- PMN Nasdaq
- Market Cap
- BRN 13.9M
- PMN 16.0M
- IPO Year
- BRN N/A
- PMN N/A
- Fundamental
- Price
- BRN $1.25
- PMN $0.40
- Analyst Decision
- BRN
- PMN Strong Buy
- Analyst Count
- BRN 0
- PMN 2
- Target Price
- BRN N/A
- PMN $4.50
- AVG Volume (30 Days)
- BRN 1.4M
- PMN 63.7K
- Earning Date
- BRN 08-12-2025
- PMN 08-07-2025
- Dividend Yield
- BRN N/A
- PMN N/A
- EPS Growth
- BRN N/A
- PMN N/A
- EPS
- BRN N/A
- PMN N/A
- Revenue
- BRN $19,387,000.00
- PMN N/A
- Revenue This Year
- BRN N/A
- PMN N/A
- Revenue Next Year
- BRN N/A
- PMN N/A
- P/E Ratio
- BRN N/A
- PMN N/A
- Revenue Growth
- BRN N/A
- PMN N/A
- 52 Week Low
- BRN $1.08
- PMN $0.38
- 52 Week High
- BRN $2.53
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- BRN 48.63
- PMN 32.23
- Support Level
- BRN $1.08
- PMN $0.48
- Resistance Level
- BRN $1.22
- PMN $0.50
- Average True Range (ATR)
- BRN 0.09
- PMN 0.03
- MACD
- BRN -0.01
- PMN -0.01
- Stochastic Oscillator
- BRN 34.02
- PMN 18.75
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.